Table 3.
Author | ESC/ERS PH Clinical group | Mean PA pressure (mmHg) | Target SVT | Success rate | Complications |
---|---|---|---|---|---|
Tongers et al.5 | 1, 4 (n = unknown) | 50 ± 10 | AVNRT: 3 | 100% (3/3) | 0% (0/8) |
AFL: 5 | 100% (5/5) | ||||
Bradfield et al.6 | 1 (n = 11), | 99 ± 35 | AFL: 12 | 86% (12/14) | 14% (2/14) |
4 (n = 1) | (systolic PA) | Right heart failure: 1 | |||
Death: 1 | |||||
Showkathali et al.16 | 1 (n = 11), | 54.5 ± 11.1 | AFL: 22 | 100% (22/22) | 0% (0/22) |
4 (n = 11) | |||||
Luesebrink et al.17 | 1 (n = 3), 2 (n = 32), 4 (n = 3) | 36.3 ± 13.5 | AFL | 100% (38/38) | 0% (0/38) |
Bandorski et al. 20) | 1 (n = 14), 2 (n = 23), 3 (n = 4), 4 (n = 8), 5 (n = 2), other (n = 4) | Unknown | AFL: 14 | 86% (12/14) | Unknown |
AT: 11 | 18% (2/11) | ||||
IART: 2 | 100% (2/2) | ||||
AVNRT: 4 | 100% (4/4) |
AFL: common atrial flutter, AT: atrial tachycardia, AVNRT: atrioventricular nodal reentrant tachycardia, ERS: European Respiratory Society, ESC: European Society of Cardiology, IART: intra-atrial reentrant tachycardia, PA: pulmonary arterial, PH: pulmonary hypertension, RFCA: radiofrequency catheter ablation, SD: standard deviation, SVT: supraventricular tachycardia.